Table 7 Receiver operating characteristics of salivary cytokines in stimulated saliva of stroke patients and healthy controls.

From: Salivary cytokine profile in patients with ischemic stroke

Salivary biomarker

SWS

AUC

95% CI

p-value

Cut off

Sensitivity%

95% CI

Specificity%

95% CI

TNF-α

Concentration (pg/mL)

0.9984

0.9931–1.000

< 0.0001

> 4.941

100

86.68–100.0

96

80.46–99.79

Output (pg/min)

0.5616

0.3950–0.7282

0.4551

> 4.211

52

33.50–69.97

76

56.57–88.50

Specific amount (ng/mg protein)

1

1.000–1.000

< 0.0001

> 4.249

100

86.68–100.0

100

86.68 -100.0

IL-6

Concentration (pg/mL)

1

1.000–1.000

< 0.0001

> 8.986

100

86.68–100.0

100

86.68–100.0

Output (pg/min)

0.536

0.3704–0.7016

0.6624

> 6.640

60

40.74–76.60

60

40.74–76.60

Specific amount (ng/mg protein)

0.9968

0.9882–1.000

< 0.0001

> 8.366

96

80.46–99.79

100

86.68–100.0

IL-10

Concentration (pg/mL)

0.9984

0.9931–1.000

< 0.0001

< 0.3165

96

80.46–99.79

100

86.68–100.0

Output (pg/min)

1

1.000–1.000

< 0.0001

< 0.2250

100

86.68–100.0

100

86.68–100.0

Specific amount (ng/mg protein)

0.9136

0.8353–0.9919

< 0.0001

< 0.2665

76

56.57–88.50

96

80.46–99.79

TNF-α/IL-10

1

1.000–1.000

< 0.0001

> 17.01

100

86.68–100.0

100

86.68–100.0

IL-6/IL-10

1

1.000–1.000

< 0.0001

> 24.60

100

86.68–100.0

100

86.68–100.0

  1. TNF-α tumor necrosis factor α, IL-6 interleukin 6, IL-10 interleukin 10.